Cancer Biology and Medicine
Cancer Biology and Medicine is a journal indexed in SJR in Oncology and Cancer Research with an H index of 69. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1350 €. The scope of the journal is focused on cancer genetics, oncology clinical trials, targeted therapy and immunology, cancer and stem cell biology, cancer prevention and epidemiology, cancer biomarkers. It has an SJR impact factor of 1,47 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,47.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
1,47
H-index
69
Docs (year)
84
Docs 3y
310
Total refs
1735
Cites 3y
1417
Citable 3y
280
Cites/Doc 2y
4.38
Ref/Doc
20.65
Immediate OA
1350 €
Embargoed OA
NPD
Non OA / Submission
- €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology
View moreYttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
View moreCalcium channel a2d1 subunit as a novel biomarker for diagnosis of hepatocellular carcinoma
View moreBsmI (rs1544410) and FokI (rs2228570) vitamin D receptor polymorphisms, smoking, and body mass index as risk factors of cutaneous malignant melanoma in northeast Italy
View moreBrain metastasis in non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations: a report of seven cases and literature review
View moreBRAFV600E vs. TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules
View moreBRAF mutation in colorectal carcinomas with signet ring cell component
View moreBone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang
View moreBiology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences
View moreBenefit of everolimus as a monotherapy for a refractory breast cancer patient bearing multiple genetic mutations in the PI3K/AKT/mTOR signaling pathway
View moreAutophagic flux response and glioblastoma sensitivity to radiation
View moreAttenuated plasmodium sporozoite expressing MAGE-A3 induces antigen-specific CD8+ T cell response against lung cancer in mice
View moreATM in breast and brain tumors: a comprehensive review
View more2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma
View moreAlterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options
View moreAggressive primary hepatic epithelioid hemangioendothelioma: a case report and literature review
View moreAdvances in isolation and detection of circulating tumor cells based on microfluidics
View moreAdvances in caring for the older cancer patient: a report from the 2015 conference of the International Society of Geriatric Oncology
View moreAdjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients
View moreAberrant expression of enzymes regulating m6A mRNA methylation: implication in cancer
View moreA race to uncover a panoramic view of primary liver cancer
View moreA new tumor-associated antigen prognostic scoring system for spontaneous ruptured hepatocellular carcinoma after partial hepatectomy
View moreA new combined criterion to better predict malignant lesions in patients with pancreatic cystic neoplasms
View more68Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomy
View more